American Capital Advisory’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
American Capital Advisory's HALO Position: Q2 2026 in Review
American Capital Advisory held its Halozyme (HALO) position steady in Q2 2026 at 1 share worth $79. The position accounts for ﹤0.01% of the portfolio, ranked #1140.
American Capital Advisory first reported a position in HALO in Q3 2025 and has held it in 4 quarters since. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- American Capital Advisory held 1 share of Halozyme worth $79 as of Q2 2026.
- American Capital Advisory left its Halozyme share count unchanged in Q2 2026.
- Halozyme made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #1140 holding.
- American Capital Advisory first reported a position in Halozyme in Q3 2025 and has held it in 4 quarters since.
- 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.